Avantax Advisory Services, Inc. Biogen Inc. Transaction History

Avantax Advisory Services, Inc.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$190.52 - $236.72 $212,810 - $264,416	1,117 New	1,117 $258,000
Q3 2023 Nov 07, 2023	SELL	$253.3 - $285.89 $3,292 - $3,716	-13 Reduced 1.54%	833 $214,000
Q2 2023 Aug 11, 2023	SELL	$275.25 - $318.06 $11,835 - $13,676	-43 Reduced 4.84%	846 $240,000
Q1 2023 Apr 28, 2023	SELL	$256.56 - $292.34 $7,953 - $9,062	-31 Reduced 3.37%	889 $247,000
Q4 2022 Feb 13, 2023	BUY	$252.44 - $306.72 $4,796 - $5,827	19 Added 2.11%	920 $254,000
Q3 2022 Nov 01, 2022	BUY	$194.69 - $268.46 $175,415 - $241,882	901 New	901 $241,000
Q2 2022 Aug 02, 2022	SELL	$187.54 - $223.02 $211,357 - $251,343	-1,127 Closed	0 $0
Q1 2022 Apr 27, 2022	SELL	$193.77 - $244.14 $6,975 - $8,789	-36 Reduced 3.1%	1,127 $236,000
Q4 2021 Jan 24, 2022	SELL	$223.92 - $287.77 $226,607 - $291,223	-1,012 Reduced 46.53%	1,163 $279,000
Q3 2021 Oct 21, 2021	BUY	$282.99 - $369.05 $183,377 - $239,144	648 Added 42.44%	2,175 $617,000
Q2 2021 Jul 29, 2021	BUY	$259.0 - $414.71 $395,493 - $633,262	1,527 New	1,527 $528,000
Q4 2020 Jan 22, 2021	SELL	$236.26 - $355.63 $414,163 - $623,419	-1,753 Closed	0 $0
Q3 2020 Oct 14, 2020	BUY	$264.77 - $305.71 $464,141 - $535,909	1,753 New	1,753 $497,000
Q2 2020 Aug 06, 2020	SELL	$258.66 - $342.55 $214,687 - $284,316	-830 Closed	0 $0
Q1 2020 Apr 30, 2020	BUY	$268.85 - $341.04 $223,145 - $283,063	830 New	830 $264,000

1,032

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Avantax Advisory Services, Inc. with notifications on news.